FdaApplication
ANDA 211276
Identifiers
- fda_app_no: ANDA211276
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | ANDA |
| approval_date | 2020-09-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DEXTROSE 5% AND SODIUM CHLORIDE 0.45% | DEXTROSE; SODIUM CHLORIDE | 5GM/100ML;450MG/100ML | INJECTABLE;INJECTION |
1 product